A New Revolutionary Technology That Can Predict Cardiovascular Risk With Precision, Part 2


Dr. Hoffman continues his conversation with Dr. James Min, an expert on cardiovascular imaging and founder and CEO of Cleerly, a company that has developed an improved scan that can differentiate between dangerous unstable plaque, and more benign lesions. Click HERE for part 1.

Subscribe to the Intelligent Medicine Podcast for Free from your Favorite Podcast Provider

Facebook Twitter YouTube RSS Google Podcasts Apple Podcasts Spotify